Ostrum Asset Management’s AbbVie ABBV Stock Holding History

Ostrum Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.63M	Buy	30,320 +334	+1%	+$71.9K	0.37%	40
2026 Q1	$6.52M	Buy	29,986 +5,725	+24%	+$1.27M	0.37%	39
2025 Q4	$5.54M	Sell	24,261 -1,499	-6%	-$341K	0.27%	51
2025 Q3	$5.96M	Sell	25,760 -5,594	-18%	-$1.14M	0.27%	56
2025 Q2	$5.82M	Sell	31,354 -2,591	-8%	-$482K	0.27%	62
2025 Q1	$7.11M	Buy	33,945 +2,738	+9%	+$532K	0.37%	41
2024 Q4	$5.55M	Sell	31,207 -564	-2%	-$104K	0.48%	32
2024 Q3	$6.27M	Buy	31,771 +561	+2%	+$105K	0.52%	32
2024 Q2	$5.35M	Sell	31,210 -8,650	-22%	-$1.43M	0.47%	35
2024 Q1	$7.26M	Sell	39,860 -3,970	-9%	-$684K	0.57%	21
2023 Q4	$6.79M	Buy	43,830 +19,028	+77%	+$2.77M	0.59%	23
2023 Q3	$3.7M	Sell	24,802 -1,943	-7%	-$285K	0.34%	67
2023 Q2	$3.6M	Sell	26,745 -287	-1%	-$42.1K	0.3%	96
2023 Q1	$4.31M	Buy	+27,032	New	+$4.13M	0.38%	67

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ostrum Asset Management's ABBV Position: Q2 2026 in Review

Ostrum Asset Management increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $71.9K and bringing the position to 30,320 shares worth $7.63M. The position accounts for 0.37% of the portfolio, ranked #40.

Ostrum Asset Management first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Ostrum Asset Management held 30,320 shares of AbbVie worth $7.63M as of Q2 2026.
Ostrum Asset Management bought 334 AbbVie shares in Q2 2026, an estimated $71.9K.
AbbVie made up 0.37% of Ostrum Asset Management's portfolio in Q2 2026, its #40 holding.
Ostrum Asset Management first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ostrum Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.